Eksempler på brug af Hypercholesterolaemia på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
Isolated or mixed hypercholesterolaemia.
Primary hypercholesterolaemia and mixed dyslipidaemia.
Primær hyperkolesterolæmi og blandet dyslipidæmi.Pravastatin has not been evaluated in patients with homozygous familial hypercholesterolaemia.
Pravastatin er ikke evalueret hos patienter med homozygot familiær hyperkolesterolæmi.Primary hypercholesterolaemia and combined(mixed) hyperlipidaemia.
Primær hyperkolesterolæmi og kombineret hyperlipidæmi.Anorexia, appetite decreased,electrolyte imbalance, hypercholesterolaemia, hyperglycaemia, hypovolaemia.
Anoreksi, nedsat appetit,forstyrrelser i elektrolytbalancen, hyperkolesterolæmi, hyperglykæmi, hypovolæmi.
Folk også translate
Primary hypercholesterolaemia is when the levels of cholesterol in the blood are high.
Primær hyperkolesterolæmi er, når blodets kolesterolindhold er højt.Tredaptive was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.
Tredaptive blev undersøgt i fire hovedundersøgelser af patienter med hyperkolesterolæmi eller blandet dyslipidæmi.Hypercholesterolaemia(including patients with heterozygous familial disease) and mixed dyslipidaemia.
Hyperkolesterolæmi(herunder patienter med heterozygot arvelig sygdom) og blandet dyslipidæmi.Elevated triglycerides, elevated amylase, abnormal fat redistribution,anorexia Hyperglycaemia, hypercholesterolaemia.
Forhøjede triglycerider, forhøjet amylase, abnorm fedtomfordeling,anorexi Hyperglykæmi, hypercholesterolæmi.Homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments e. g.
Homozygot familiær hyperkolesterolæmi, som supplement til diæt og anden lipidsænkende behandling feks.The Committee noted that across all studies in patients with primary hypercholesterolaemia and mixed dyslipidaemia.
Udvalget bemærkede, at i alle undersøgelserne hos patienter med primær hyperkolesterolæmi og blandet dyslipidæmi.Sporadic, spontaneous cases of hypercholesterolaemia have been reported, but causality has not been established.
Der er blevet rapporteret om sporadiske, spontane tilfælde af hyperkolesterolæmi, men årsagssammenhængen er ikke fastslået.Lipodystrophy(including lipohypertrophy, lipodystrophy, lipoatrophy),hypertriglyceridaemia, hypercholesterolaemia, hyperlipidaemia.
Lipodystrofi(inklusive lipohypertrofi, lipodystrofi og lipoatrofi),hypertriglyceridæmi, hyperkolesterolæmi, hyperlipidæmi.Table 1 Dose response in patients with primary hypercholesterolaemia(type IIa and IIb) adjusted mean percent change from baseline.
Dosisrespons hos patienter med primær hyperkolesterolæmi(type IIa og IIb) justeret gennemsnitsændring fra baselinien i procent.The most frequent(≥ 2%) of those were diarrhoea(3.9%), hypertriglyceridaemia(3.8%), rash(2.8%), nausea(2.6%), hypercholesterolaemia(2.5%) and headache 2.0.
De mest hyppige(≥2%) af disse rapporterede uønskede reaktioner var: diarré(3, 9%), hypertriglyceridæmi(3, 8%), udslæt(2, 8%), kvalme(2, 6%), hyperkolesterolæmi(2, 5%) og hovedpine 2, 0.Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, treatment of homozygous familial hypercholesterolaemia.
Behandling af primær hyperkolesterolæmi eller kombineret dyslipidæmi, behandling af homozygot familiær hyperkolesterolæmi.Cholestagel is prescribed to treat a condition known as isolated primary hypercholesterolaemia when cholesterol in the blood is elevated.
Cholestagel ordineres til behandling af en tilstand, der kaldes isoleret primær hyperkolesterolæmi når kolesteroltallet i blodet er for højt.Hyperlipaemia, Hypercholesterolaemia Weight Gain, SGOT Increased, SGPT Increased, Lactic Dehydrogenase Increased, Creatinine Increased, Hypoproteinaemia.
Hyperlipidæmi, hyperkolesterolæmi Vægtøgning, forhøjet SGOT, forhøjet SGPT, forhøjet laktatdehydrogenase, forhøjet kreatinin, hypoproteinæmi.The incidence of circulatory system diseases is also higher in women suffering from diabetes, hypercholesterolaemia and familial hyperlipoproteinaemia.
Forekomsten af kredsløbssygdomme er også højere i kvinder, der lider af diabetes, hyperkolesterolæmi og familiær hyperlipoproteinæmi.Praluent is indicated in adults with primary hypercholesterolaemia(heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet.
Praluent er indiceret hos voksne med primær hypercholesterolaemia(heterozygote familiær og ikke-familiær) eller blandet dyslipidaemia, som et supplement til kost.Protease inhibitors are also associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance and hyperglycaemia.
Proteasehæmmere forbindes også med metaboliske abnormiteter som f. eks. hypertriglyceridæmi, hyperkolesterolæmi, insulinresistens og hyperglykæmi.Primary hypercholesterolaemia(type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia(type IIb) as an adjunct to diet when response to diet and other non- pharmacological treatments(e. g. exercise, weight reduction) is inadequate.
Som supplement til diætbehandling ved primær hyperkolesterolæmi(type IIa inklusiv heterozygot familiær Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactaemia.
Antiretroviral kombinationsbehandling er blevet associeret med metaboliske abnormaliteter så som hypertriglyceridæmi, hyperkolesterolæmi, insulinresistens, hyperglykæmi og hyperlaktæmi.Praluent is indicated in adults with primary hypercholesterolaemia(heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet: in combination with a statin or statin with other lipid lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin or,, alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
Praluent er indiceret hos voksne med primær hypercholesterolaemia( heterozygote familiær og ikke-familiær) eller blandet dyslipidaemia, som et supplement til kost: i kombination med et statin eller statin med andre lipidsænkende behandlinger på patienter i stand til at nå LDL-C mål med den maksimalt tolererede dosis af et statin, eller,, alene eller i kombination med andre lipidsænkende behandlinger på patienter, der er statin-intolerant, eller for hvem en statin-præparat er kontraindiceret.Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia see section 4.4.
Antiveral kombinationsbehandling er også blevet associeret med metaboliske abnormiteter som hypertriglycerid,, hyperkolerolæmi, insulinresistens, hyperglyceridæmi og hyperlactatæmi se afsnit 4. 4.The most common side effects with Avandia(seen in between 1 and 10 patients in 100)are anaemia(low red blood cell counts), hypercholesterolaemia(high blood cholesterol levels), hypertriglyceridaemia(high blood levels of triglycerides, a type of fat), hyperlipaemia(high blood levels of lipids, another type of fat), weight increase, increased appetite, cardiac ischaemia(reduced oxygen supply to the heart muscle), constipation, bone fractures(broken bones), hypoglycaemia(low blood glucose) and oedema swelling.
De hyppigste bivirkninger af Avandia(som kunne observeres hos mellem 1 og10 patienter ud af 100) er anæmi(lavt antal røde blodlegemer), hypercholesterolæmi(højt blodkolesterol), hypertriglyceridæmi(forhøjet indhold af triglycerider i blodet, en bestemt type fedtstoffer), hyperlipæmi(øget fedtindhold i blodet), vægtøgning, øget appetit, hjerteiskæmi(nedsat ilttilførsel til hjertemusklen), forstoppelse, knoglefrakturer(knoglebrud), hypoglykæmi(lavt blodsukkerniveau) og ødemer hævelser.Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia see section 4.4.
Kombinationsbehandling med antiretrovirale midler er associeret med metaboliske abnormiteter som eksempelvis hypertriglyceridæmi, hypercholesterolæmi, insulinresistens, hyperglycæmi og hyperlactatæmi se pkt 4. 4.Hypercholesterolemia still is an indication, but mainly in combination with such dyslipidaemia.
Hyperkolesterolæmi er stadig en indikation, men hovedsageligt i forbindelse med en sådan dyslipidæmi.Hypercholesterolemia, weight gain, hyperglycemia, hunger.
Hyperkolesterolæmi, vægtøgning, hyperglykæmi, sult.Is recommended in liver diseases, biliary dyskinesia, gallbladder,hypertension, hypercholesterolemia, urinary lithiasis and pancreatite.
Anbefales i leversygdomme, biliær dyskinesi, galdeblæren,hypertension, hyperkolesterolæmi, urin lithiasis og pancreatite.
